Inhibition of PAX3 by TGF-beta modulates melanocyte viability

Guang Yang1, Yitang Li, Emi K Nishimura

  • 1Department of Medical Oncology, Dana-Farber Cancer Institute, Children's Hospital Boston, Harvard Medical School, 44 Binney Street, Boston, MA 02115, USA.

Molecular Cell
|November 26, 2008
PubMed

Insights

UV light boosts skin pigmentation by reducing TGF-beta inhibition on PAX3, activating melanogenesis. This pathway interacts with p53 signaling, crucial for UV-induced tanning and potential skin cancer prevention.

Area of Science:

  • Dermatology
  • Molecular Biology
  • Genetics

Background:

  • Paired-box homeotic gene 3 (PAX3) regulates the microphthalmia-associated transcription factor (Mitf) in melanocytes.
  • TGF-beta/Smads signaling is known to inhibit PAX3 expression.

Purpose of the Study:

  • To elucidate the role of the TGF-beta-PAX3 signaling pathway in UV-induced melanogenesis.
  • To investigate the interaction between TGF-beta-PAX3 and p53-POMC/MSH-MC1R pathways in skin pigmentation.

Main Methods:

  • Investigated the regulation of PAX3 by TGF-beta/Smads in skin cells.
  • Examined the effect of UV irradiation on TGF-beta signaling in keratinocytes.
  • Analyzed the synergistic function of PAX3 and SOX10 in regulating Mitf transcription.

Main Results:

  • UV irradiation represses TGF-beta in keratinocytes, leading to increased PAX3 expression in melanocytes.
  • This upregulation of PAX3 is linked to UV-induced melanogenesis and pigmentation.
  • The TGF-beta-PAX3 pathway interacts with the p53-POMC/MSH-MC1R pathway, both essential for melanogenesis.

Conclusions:

  • PAX3 upregulation, driven by UV-induced TGF-beta repression, is a key event in melanogenesis.
  • The interplay between TGF-beta-PAX3 and p53-POMC/MSH-MC1R pathways is critical for UV-induced pigmentation.
  • Findings offer a basis for developing small molecules for skin cancer prevention via targeted melanogenesis pathways.